当前位置: 首页 > 详情页

Mesenchymal stem cells for stroke therapy

文献详情

资源类型:
机构: [1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University, Beijing, China [2]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China [3]Institute of Hypoxia Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China [4]China-America Joint Institute for Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China [5]Department of Neurology, Henry Ford Hospital, Detroit, MI, USA
出处:

关键词: Immunomodulatory Mesenchymal stem/stromal cells Neurotrophic Stroke Transplantation

摘要:
Mesenchymal stem/stromal cells (MSCs) from different sources have been tested in experimental ischemic stroke and been proved effective in many studies. More understanding of the underlying mechanisms for MSC therapy is essential for improving the therapeutic efficacy and ameliorating or avoiding side effects. In this chapter, we reviewed progress in the field that includes the following aspects: (1) the neurotrophic and immunomodulatory functions of MSCs, the two main mechanisms through which MSCs exert effects in stroke treatment; (2) the aging and senescence of MSCs and their influence on outcome; (3) how autologous MSCs derived from diseased patients may affect the therapeutic effects; (4) different sources of MSCs and comparison of their effects in therapy; and (5) time of transplantation and the delivery methods. © Springer Nature Singapore Pte Ltd. 2017.

语种:
第一作者:
第一作者机构: [1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构: [1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院